Back to results
US 5,990,087 AGranted
Human ena/VASP-like protein splice variant
AssigneeIncyte Pharmaceuticals, Inc.
InventorsPreeti Lal, Karl J. Guegler, Neil C. Corley
Life of this patent
Estimating the term…
Abstract
The invention provides a human ena/VASP-like protein splice variant (EVL1) and polynucleotides which identify and encode EVL1. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of EVL1.
Claims2
A substantially purified polypeptide comprising the amino acid sequence of SEQ ID NO:1.
Dependencies are inferred from the claim text.